ES436362A1 - (3beta-hydroxy-2beta-(substituted-1-alkenyl)-5-oxo-1alpha-cyclopentyl)heptanoic acids - Google Patents
(3beta-hydroxy-2beta-(substituted-1-alkenyl)-5-oxo-1alpha-cyclopentyl)heptanoic acidsInfo
- Publication number
- ES436362A1 ES436362A1 ES436362A ES436362A ES436362A1 ES 436362 A1 ES436362 A1 ES 436362A1 ES 436362 A ES436362 A ES 436362A ES 436362 A ES436362 A ES 436362A ES 436362 A1 ES436362 A1 ES 436362A1
- Authority
- ES
- Spain
- Prior art keywords
- atoms
- denotes
- alkyl radical
- hydroxy
- 2beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 abstract 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000005907 alkyl ester group Chemical group 0.000 abstract 1
- 230000003509 anti-fertility effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- 229910052744 lithium Inorganic materials 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- -1 magnesium halogen Chemical class 0.000 abstract 1
- 150000002902 organometallic compounds Chemical class 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Prostanoic acid derivatives of the following formula < IMAGE > are prepared, in which R' denotes an alkyl radical having 1-7 C atoms and R'' denotes a straight-chain alkyl radical having 6-9 C atoms. These compounds are obtained by reacting an appropriate ketone, which is optionally protected on the hydroxy group, with an organometallic compound of the formula R'M or R''M in which M denotes lithium or magnesium halogen to introduce the substituent R' or R'' and optionally subsequently removing the protective group. The compound of the formula I, which is present as the free acid, can be converted into alkyl esters having 1-7 C atoms in the alkyl radical. On account of their antifertility properties, the prostanoic acid derivatives are utilisable pharmaceutical agents.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45879974A | 1974-04-08 | 1974-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES436362A1 true ES436362A1 (en) | 1977-01-01 |
Family
ID=23822127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES436362A Expired ES436362A1 (en) | 1974-04-08 | 1975-04-07 | (3beta-hydroxy-2beta-(substituted-1-alkenyl)-5-oxo-1alpha-cyclopentyl)heptanoic acids |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS5835183B2 (en) |
AT (1) | AT348154B (en) |
BE (1) | BE827694A (en) |
CA (1) | CA1071625A (en) |
CH (1) | CH609971A5 (en) |
DE (1) | DE2515115A1 (en) |
DK (1) | DK147075A (en) |
ES (1) | ES436362A1 (en) |
FR (1) | FR2266500B1 (en) |
GB (1) | GB1496716A (en) |
IE (1) | IE41470B1 (en) |
NL (1) | NL7504104A (en) |
SE (1) | SE420998B (en) |
ZA (1) | ZA752183B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60102774U (en) * | 1983-12-14 | 1985-07-13 | ソニー株式会社 | floppy disc cassette |
JPS60106272U (en) * | 1983-12-24 | 1985-07-19 | ソニー株式会社 | floppy disc cassette |
JPS60106271U (en) * | 1983-12-24 | 1985-07-19 | ソニー株式会社 | floppy disc cassette |
JPS60140266U (en) * | 1984-02-25 | 1985-09-17 | ソニー株式会社 | magnetic disk device |
JPS6121075U (en) * | 1984-07-07 | 1986-02-06 | ティーディーケイ株式会社 | disk cartridge |
-
1975
- 1975-04-07 AT AT261475A patent/AT348154B/en not_active IP Right Cessation
- 1975-04-07 ES ES436362A patent/ES436362A1/en not_active Expired
- 1975-04-07 CA CA223,911A patent/CA1071625A/en not_active Expired
- 1975-04-07 DK DK147075A patent/DK147075A/da not_active IP Right Cessation
- 1975-04-07 JP JP50042157A patent/JPS5835183B2/en not_active Expired
- 1975-04-07 NL NL7504104A patent/NL7504104A/en not_active Application Discontinuation
- 1975-04-07 DE DE19752515115 patent/DE2515115A1/en not_active Withdrawn
- 1975-04-07 IE IE767/75A patent/IE41470B1/en unknown
- 1975-04-07 ZA ZA00752183A patent/ZA752183B/en unknown
- 1975-04-07 GB GB14093/75A patent/GB1496716A/en not_active Expired
- 1975-04-07 SE SE7503928A patent/SE420998B/en unknown
- 1975-04-08 FR FR7510936A patent/FR2266500B1/fr not_active Expired
- 1975-04-08 CH CH444075A patent/CH609971A5/en not_active IP Right Cessation
- 1975-04-08 BE BE155198A patent/BE827694A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NL7504104A (en) | 1975-10-10 |
IE41470L (en) | 1975-10-08 |
CH609971A5 (en) | 1979-03-30 |
DK147075A (en) | 1975-10-09 |
SE7503928L (en) | 1975-10-09 |
FR2266500A1 (en) | 1975-10-31 |
BE827694A (en) | 1975-10-08 |
JPS5835183B2 (en) | 1983-08-01 |
GB1496716A (en) | 1977-12-30 |
IE41470B1 (en) | 1980-01-16 |
FR2266500B1 (en) | 1978-07-28 |
SE420998B (en) | 1981-11-16 |
ATA261475A (en) | 1978-06-15 |
AU7990675A (en) | 1976-10-14 |
ZA752183B (en) | 1976-06-30 |
DE2515115A1 (en) | 1975-10-16 |
AT348154B (en) | 1979-02-12 |
JPS50137960A (en) | 1975-11-01 |
CA1071625A (en) | 1980-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES436362A1 (en) | (3beta-hydroxy-2beta-(substituted-1-alkenyl)-5-oxo-1alpha-cyclopentyl)heptanoic acids | |
ES489823A1 (en) | Catalyst, its preparation and process for polymerizing butadiene. | |
ES435498A1 (en) | Procedure for the preparation of 1- (3,5-dihydroxypenyl) -1-hydroxy-2- (1-methyl-2- (4-hydroxypenyl) -etil) -aminoethane. (Machine-translation by Google Translate, not legally binding) | |
GB1496491A (en) | Dihydroergopeptine derivatives | |
JPS5223145A (en) | Process for preparing a modified polyolefin composition | |
AU529883B2 (en) | Substituted cyclopentenones | |
CH608785A5 (en) | Process for producing new N-acylglutamines | |
GB1353898A (en) | Alicyclic ketoesters | |
ES434405A1 (en) | Procedure for the preparation of imidazole derivatives. (Machine-translation by Google Translate, not legally binding) | |
GB1381442A (en) | Process for the preparation of prostaglandin precursors | |
ES397453A1 (en) | Imidazoline derivatives of benzonorbornane and tetrahydronaphthalene compounds | |
ES441775A1 (en) | Anthraquinone dyes | |
GB1341204A (en) | Process for the manufacture of triarylmethane compounds | |
ES446239A1 (en) | 8-azaprostaglandins and process for the preparation thereof | |
GB1174385A (en) | 0-Pyridyl-1,2,3,4-Tetrahydroisoquinoline Derivatives | |
ES401264A1 (en) | Penicillins | |
GB1412663A (en) | 2- 4-biphenylyl- tetrahydrofurans and pharmaceutical compositions containing them | |
GB1292662A (en) | Bicycloheptaneheptanoic acids and esters thereof | |
ES405048A1 (en) | Phenothiazine derivatives | |
ES396825A1 (en) | Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon | |
ES343416A1 (en) | 1-substituted-2-alkyl-5-nitroimidazoles | |
ES417883A1 (en) | Substituted 4-biphenylyl-butenoic acids esters and amides and pharmaceutical compositions containing them | |
ES450472A1 (en) | Benzoyl pyrazole 5-acetic acid derivatives useful as uricosurucs | |
JPS5283436A (en) | Preparation of intermediates for synthesis of prostaglandin | |
GB1432734A (en) | Process for the manufacture of trichlorocarboxylic acids esters and salts |